Status:
COMPLETED
Immune Response in Dialysis Patients Vaccinated Against COVID-19
Lead Sponsor:
Saint Petersburg State University, Russia
Conditions:
Covid19
Chronic Kidney Disease 5D
Eligibility:
All Genders
18+ years
Brief Summary
This is a prospective cohort study aimed to evaluate short- and mid-term immune response after SARS-CoV-2 vaccination using Gam-COVID-Vac (Sputnik V) vaccine in dialysis patients compared to the contr...
Detailed Description
Background and aims: Patients receiving kidney replacement therapy with dialysis are at high risk of infection and death from COVID-19. There is a lack of evidence whether SARS-CoV-2 vaccination is ef...
Eligibility Criteria
Inclusion
- Age of 18 years or older
- Previously vaccinated against SARS-CoV-2 with two administrations of Gam-COVID-Vac (Sputnik V) vaccine
- Written informed consent.
Exclusion
- A history of previous COVID-19 disease
- Active malignancy of any localization
- Human Immunodeficiency Virus (HIV) infection
- Maintenance treatment with immunosuppressive therapy.
Key Trial Info
Start Date :
March 23 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 30 2022
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT04805632
Start Date
March 23 2021
End Date
January 30 2022
Last Update
April 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saint-Petersburg State University Hospital
Saint Petersburg, Russia, 190103